Insider Selling: West Pharmaceutical Services VP Unloads 9,800 Shares of Stock (WST)
West Pharmaceutical Services (NYSE:WST) VP Michael A. Anderson sold 9,800 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $43.41, for a total transaction of $425,418.00. Following the completion of the sale, the vice president now directly owns 70,713 shares of the company’s stock, valued at approximately $3,069,651. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of West Pharmaceutical Services in a research note on Tuesday, August 5th. They now have a $45.00 price target on the stock, down previously from $47.00.
West Pharmaceutical Services (NYSE:WST) traded up 0.25% on Thursday, hitting $44.05. The stock had a trading volume of 415,934 shares. West Pharmaceutical Services has a 1-year low of $36.77 and a 1-year high of $51.12. The stock has a 50-day moving average of $41.21 and a 200-day moving average of $43.32. The company has a market cap of $3.117 billion and a price-to-earnings ratio of 27.77.
West Pharmaceutical Services (NYSE:WST) last released its earnings data on Thursday, July 31st. The company reported $0.52 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.47 by $0.05. The company had revenue of $368.90 million for the quarter, compared to the consensus estimate of $368.60 million. During the same quarter last year, the company posted $0.86 earnings per share. West Pharmaceutical Services’s revenue was up 7.1% compared to the same quarter last year. On average, analysts predict that West Pharmaceutical Services will post $1.84 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Wednesday, November 5th. Shareholders of record on Wednesday, October 22nd will be given a dividend of $0.11 per share. This represents a $0.44 dividend on an annualized basis and a yield of 1.00%.
West Pharmaceutical Services, Inc (NYSE:WST) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.